Cargando…

Cardiac Autonomic Dysfunction in Multiple Sclerosis: A Systematic Review of Current Knowledge and Impact of Immunotherapies

Cardiac autonomic dysfunction (CAD) has been reported in patients with multiple sclerosis (MS). This systematic review summarizes the evidence for the types and prevalence of CAD in MS patients, as well as its association with MS type, disease characteristics, fatigue and immunotherapies used to tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Findling, Oliver, Hauer, Larissa, Pezawas, Thomas, Rommer, Paulus S., Struhal, Walter, Sellner, Johann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073977/ https://www.ncbi.nlm.nih.gov/pubmed/31991711 http://dx.doi.org/10.3390/jcm9020335

Ejemplares similares

Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies
por: Sellner, Johann, et al.
Publicado: (2021)

Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data
por: Hauer, Larissa, et al.
Publicado: (2022)

A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications
por: Hauer, Larissa, et al.
Publicado: (2020)

Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats
por: Feige, Julia, et al.
Publicado: (2020)

Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis—A Cohort Study
por: Findling, Oliver, et al.
Publicado: (2015)

Heart Rate Spectra Confirm the Presence of Autonomic Dysfunction in Dementia Patients
por: Struhal, Walter, et al.
Publicado: (2016)

Immunological Aspects of Approved MS Therapeutics
por: Rommer, Paulus S., et al.
Publicado: (2019)

Humoral Immune Response after the Third SARS-CoV-2 mRNA Vaccination in CD20 Depleted People with Multiple Sclerosis
por: Achtnichts, Lutz, et al.
Publicado: (2021)

Myalgische Enzephalomyelitis/chronisches Fatigue-Syndrom: eine Übersicht zur aktuellen Evidenz
por: Ludwig, Birgit, et al.
Publicado: (2023)

Autonomic Dysfunction Predicts Early Cardiac Affection in Patients with Systemic Sclerosis
por: Othman, Khaled M., et al.
Publicado: (2010)

Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients
por: Rommer, Paulus S., et al.
Publicado: (2020)

SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis Treated with Fingolimod: Protective Humoral Immune Responses May Develop after the Preferred Third Shot
por: Achtnichts, Lutz, et al.
Publicado: (2022)

An overview of pivotal trials and real-world evidence for CD20-depleting therapy in multiple sclerosis: Immunotherapy with rituximab, ocrelizumab, and ofatumumab
por: Ovchinnikov, Arkady, et al.
Publicado: (2022)

Retinal imaging with optical coherence tomography in multiple sclerosis: novel aspects
por: Olbert, Elisabeth, et al.
Publicado: (2022)

Clinical Challenges in a 49-Year-Old Patient with Severe Tick-Borne Myeloradiculitis Despite Complete Active Vaccination
por: Feige, Julia, et al.
Publicado: (2020)

Predisposing Factors for Sexual Dysfunction in Multiple Sclerosis
por: Altmann, Patrick, et al.
Publicado: (2021)

Multiple sclerosis at the crossroads of scientific evidence and clinical translation
por: Sellner, Johann
Publicado: (2022)

Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study
por: Karamyan, Anush, et al.
Publicado: (2016)

Cerebral HSV-1 Vasculitis as a Fatal Complication of Immunosuppression in Non-Hodgkin´s Lymphoma: A Case Report and Review of the Literature
por: Nardone, Raffaele, et al.
Publicado: (2020)

Cardiac Autonomic Dysfunction in Myasthenia Gravis and Relapsing-Remitting Multiple Sclerosis—A Pilot Study
por: Rzepiński, Łukasz, et al.
Publicado: (2021)

Continuous monitoring with wearables in multiple sclerosis reveals an association of cardiac autonomic dysfunction with disease severity
por: Hilty, Marc, et al.
Publicado: (2022)

Brugada Syndrome Caused by Autonomic Dysfunction in Multiple Sclerosis
por: Ibrahim, Michel, et al.
Publicado: (2019)

Cerebrovascular manifestations of herpes simplex virus infection of the central nervous system: a systematic review
por: Hauer, Larissa, et al.
Publicado: (2019)

E-learning preferences of European junior neurologists—an EAYNT survey
por: Sztriha, Laszlo K., et al.
Publicado: (2012)

Coping behavior in multiple sclerosis—complementary and alternative medicine: A cross‐sectional study
por: Rommer, Paulus S, et al.
Publicado: (2018)

Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care
por: Jalusic, Kris Oliver, et al.
Publicado: (2021)

Epileptic seizures at multiple sclerosis onset and their role in disease progression
por: Grothe, Matthias, et al.
Publicado: (2023)

Therapy of Dysphagia by Prolonged Pharyngeal Electrical Stimulation (Phagenyx) in a Patient with Brainstem Infarction
por: Florea, Cristina, et al.
Publicado: (2020)

Intracranial Vertebrobasilar Calcification in Patients with Ischemic Stroke Is a Predictor of Recurrent Stroke, Vascular Disease, and Death: A Case-Control Study
por: Magdič, Jožef, et al.
Publicado: (2020)

Cardiovascular autonomic function testing in multiple system atrophy and Parkinson’s disease: an expert-based blinded evaluation
por: Leys, Fabian, et al.
Publicado: (2020)

Clinical autonomic nervous system laboratories in Europe: A joint survey of the European Academy of Neurology and the European Federation of Autonomic Societies
por: Habek, Mario, et al.
Publicado: (2022)

Herpes Simplex Virus Type 2 Myelitis: Case Report and Review of the Literature
por: Nardone, Raffaele, et al.
Publicado: (2017)

Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety
por: Moser, Tobias, et al.
Publicado: (2022)

Natalizumab extended-interval dosing in multiple sclerosis to mitigate progressive multifocal leukoencephalopathy risk: initial study evidence and real-world experience
por: Perncezky, Julian, et al.
Publicado: (2022)

Clinical study of cardiac autonomic dysfunction in HIV patients
por: Mathew, Pradheep C, et al.
Publicado: (2014)

Cardiac autonomic dysfunction in obese normotensive children and adolescents
por: Freitas, Isabelle Magalhães G., et al.
Publicado: (2014)

Cardiac autonomic dysfunction in adult congenital heart disease
por: Pizarro, Carmen, et al.
Publicado: (2023)

COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry
por: Bsteh, Gabriel, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in multiple sclerosis: A clearer picture for the time point during CD20 depleting therapy
por: Schulte, Eva C., et al.
Publicado: (2021)

Vaccination in Multiple Sclerosis: Friend or Foe?
por: Zrzavy, Tobias, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_chm4dijgi71v710tpvqukt4v60